Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Research Impact Video
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health and Artificial Intelligence
      • Heart Health
      • Healthy Aging and Mobility
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Cardiovascular Innovation
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
      • Learning and Development
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
      • CST Cerner
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Indigenous Health Research Unit
      • VCH-VCHRI AI Hub
      • Communications and Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. News and Stories
  4. Diet and microbiome potentially linked to childhood-onset multiple sclerosis

Diet and microbiome potentially linked to childhood-onset multiple sclerosis

Stories Nov 12, 2024 3 minutes

A novel study has collected important data on the association between a high-fibre Mediterranean diet, the microbiome and MS in pediatric patients.

A first-of-its-kind study led by Vancouver Coastal Health Research Institute researcher Dr. Helen Tremlett and Dr. Ali Mirza, along with an international team of researchers, has identified statistically significant links between diet, gut microbiota and multiple sclerosis (MS). Published in Nature, Communications Medicine, researchers found that the consumption of a Mediterranean diet was associated with lower odds of pediatric-onset MS.

Dr. Helen Tremlett is a professor in the Division of Neurology at the University of British Columbia (UBC) and the Djavad Mowafaghian Centre for Brain Health. She is also the head of the Pharmacoepidemiology in Multiple Sclerosis Research Group (PiMS Research Group).

There is presently no cure for MS, a neurological disease that attacks the myelin sheath covering nerves in the central nervous system, including the brain, spinal cord and optic nerves. The condition causes episodic and sometimes progressive symptoms, such as cognitive impairment, extreme fatigue, weakness, lack of coordination, impaired sensation, vision problems, mood changes and bladder problems. 

Around 90,000 Canadians are living with MS, with approximately 12 Canadians diagnosed each day, most between the ages of 20 and 49. Globally, Canada has one of the highest prevalences of MS, with over 200 cases per 100,000 individuals.

The role of fibre in immune function, brain health and inflammation

“The link between diet and gut microbiota in individuals with MS is largely unexplored and not well understood,” says Mirza. “We were interested in uncovering how diet and gut bacteria are linked to MS in young people, examining the diet and types of bacteria in stool samples from those with and without MS.”

“A main advantage of this study is that we looked at pediatric patients who had fewer confounders, such as other health conditions, that could have impacted our results.”

Tremlett and Mirza’s study included 95 individuals aged 21 years or younger. Of these, 44 were diagnosed with MS when they were under 18 years of age and 51 were healthy controls. Data was sourced from the Canadian Pediatric Demyelinating Disease Network study, which included individuals from six Canadian sites and one site in the United States. All individuals had completed a food frequency questionnaire that tracked their food intake when they were 21 years of age or younger, and researchers also had access to stool samples provided by 59 individuals.

“We found that a diet rich in fibre and Mediterranean foods was less common in those with MS,” says Mirza. “This dietary pattern was linked to certain differences in gut bacteria, raising the possibility that the consumption of high-fibre foods and a Mediterranean diet could have a protective effect against MS by impacting individuals’ gut bacteria.”

Individuals who more strictly followed the Mediterranean diet were associated with lower odds of MS-onset by 37 per cent or more, Mirza asserts.

“This research opens the door to further studies on how diet might influence MS through the gut microbiome and, vice versa, how having MS might influence the diet and the gut microbiome.”

The Mediterranean diet is based on the consumption of more vegetables, fruits, whole grains, legumes, nuts, seeds and olives. It champions eating small amounts of red meat and moderate amounts of fish and poultry, along with choosing olive oil as a main source of fat, according to the Dietitians of Canada. The healthy eating approach is also high in fibre.

Fibre was associated with a healthier gut microbiome among individuals in Tremlett and Mirza’s study. High fibre intake supported beneficial bacteria in the gut, such as the Ruminococcaceae species. However, lower fibre intake was linked with an increased presence of certain bacteria, such as Methanobrevibacter, which has also been associated with MS.

Dr. Ali Mirza is a researcher at Integrated Microbiome Platforms for Advancing Causation Testing and Translation.

“Healthy gut bacteria produce short-chain fatty acids in the body, which have anti-inflammatory effects that support healthy immune function and brain activity,” explains Mirza. “Unhealthy bacteria can have the reverse effect, increasing inflammation that can be harmful to tissues.”

Diets high in fibre have also been shown to alleviate constipation, which is a common concern among people with MS. 

Future research is needed to further tease out these novel associations between diet, the gut microbiome and MS.

Learn more about the gut microbiome and MS on Tremlett’s MS Research Explained blog.
 

Researchers

Helen Tremlett

Related Articles

Living in wealthier communities decreased death for Canadians with MS

Heart attack risk found to be higher for people with multiple sclerosis

Common treatment for multiple sclerosis may prolong life

Share:

  • Facebook
  • Linkedin
  • Twitter
  • Email

Related Research Centres/Programs

Djavad Mowafaghian Centre for Brain Health

Get the latest research headlines in your inbox

Subscribe

Recent News and Stories

Type
Announcement

Celebrating the life and distinguished career of Dr. Marcel Dvorak

May 14, 2025
Type
Stories

More equitable representation needed in Parkinson’s research

May 9, 2025 parkinsons, patient engagement, women
Type
Stories

Gamified stroke recovery improves arm function

May 8, 2025 stroke, rehabilitation
See more news

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • X
  • YouTube

© 2025 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy